Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington Disease

Condition:   Huntington Disease Intervention:   Genetic: intra-striatal rAAV5-miHTT Sponsor:   UniQure Biopharma B.V. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials